A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.


Updates from The Motley Fool

Latest updates on Novavax from Fool.com.  The Fool has written over 100 articles on Novavax.
3 Stocks to Avoid in Biotech

Biotech stocks are known for their high growth, but they can also be toxic for your portfolio if ...

2016's Worst Clinical Failures

It's been a rough year for drugmakers, but late clinical-stage failures made it especially tough ...

4 Stocks I'd Avoid at All Costs

Whether you're interested in these biotech stocks or not, there are some important lessons to be ...

3 Stocks to Avoid in Biotech

Buying biotech stocks has always been a risky business, but these three are best left on the shelf.



Stock Performance

View Interactive NVAX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Novavax.
Current Price: $1.02
Prev Close: $1.02
Open: $1.02
Bid: $1.01
Ask: $1.02
Day's Range: $0.98 - $1.02
52wk Range: $0.73 - $8.49
Volume: 2,179,560
Avg Vol 6,639,022
Market Cap: $288M
P/E (ttm): -1.13
EPS (ttm): ($0.90)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Novavax.
CAPS Rating 2 out of 5
 
300 Outperform
84 Underperform
CAPS All Stars
 
41 Outperform
16 Underperform

How do you think Novavax will perform against the market?



You pick for Novavax is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Stanley C. Erck, CEO

68% Approve

Based on 30 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Novavax.

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers